• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Disinfection robots, Google Glass, artificial pancreas top hospitals’ tech list

Disinfection robots, Google Glass, artificial pancreas top hospitals’ tech list

January 20, 2015 By Brian Johnson

Disinfection robots, Google Glass, artificial pancreas top hospitals' tech list

Automated robotic systems used to combat hospital-acquired infections topped the ECRI Institute’s "2015 Top 10 Hospital C-Suite Watch List," an annual report on technologies healthcare executives should look out for in the next year to 18 months.

The robots use UV radiation and other light-based technologies to kill spores found in methicillin-resistant Staphylococcus aureus and C. difficile. The devices are costly, with price tags ranging from $47,000 to $125,000, but the cost of battling the drug-resistant bugs are high too. ECRI noted that the capital equipment could have "large positive implications for infection prevention practices and capital and operational budgets," according to the institute.

Memphis-based Lumalier Corp., San Antonio-based Xenex Disinfection Services and Horsham, Pa.-based Bioquell were highlighted by ECRI as vendors of the anti-infection robots.

Hospital-acquired infection rates have exploded in recent years, with 1 in 25 patients reporting at least 1 HAI on any given day, according to the Centers for Disease Control. Hospital-acquired infections result in about 75,000 deaths annually, according to the CDC.

ECRI also flagged the much-maligned Google Glass platform as a potentially transformative technology, even though the Silicon Valley goliath halted sales of the Glass consumer product this week.

EnteroMedics (NSDQ:ETRM), which this week won pre-market approval from the FDA for its anti-obesity Maestro neurostimulation implant, also drew a nod from ECRI as 1 of 3 minimally invasive devices designed to combat less severe obesity. The Endobarrier made by GI Dynamics (ASX:GID) and ReShape Medical‘s Duo system also made the list of bariatric devices to watch. Of the 3 devices, only EnteroMedics’ Maestro has been approved for use in the U.S.

Other technologies the institute highlighted included artificial pancreas device systems and 3D printers. To download the full watch list, click here.

Filed Under: Hospital Care, News Well Tagged With: Alphabet (Google), Bariatrics, EnteroMedics Inc., GI Dynamics, Patient Safety, ReShape Lifesciences, Technology

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy